Mabion S.A. (WSE:MAB)
Poland
· Delayed Price · Currency is PLN 7.13
+0.11 (1.57%)
Dec 5, 2025, 5:00 PM CET
Mabion Company Description
Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.
It offers drug substance manufacturing, fill and finish, gene to vial end-to-end development, process development, analytics, and banking services.
In addition, it offers cell line development, process development, production of a product for preclinical and clinical trials, development and validation of analytical methods, and preparation of the necessary documentation.
The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland.
Mabion S.A.
| Country | Poland |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 213 |
| CEO | Krzysztof Kaczmarczyk |
Contact Details
Address: Medical Biotechnology Scientific and Industrial Complex Konstantynów Lódzki, 95-050 Poland | |
| Phone | 48 42 207 7890 |
| Website | mabion.eu |
Stock Details
| Ticker Symbol | MAB |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLMBION00016 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Krzysztof Kaczmarczyk | Chief Executive Officer and President of Management Board |
| Grzegorz Grabowicz | Chief Financial Officer and Financial Director |
| Adam Pietruszkiewicz | Chief Commercial Officer, Business Development Director and Member of Management Board |
| Julita Balcerek M.D. | Member of the Management Board, Operations Director and Chief Operating Officer |
| Pawel Pobiedzinski | Head of Logistics and Procurement |
| Joanna Krolasik | Head of Microbiology Laboratory |